Not applicableUnknownNCT01590498What this trial is testingRadiotherapy vs Observation for CRPCWho this might be right forHormone Refractory Prostate Cancer Zhengzhou University 2,000
Not applicableEnded earlyNCT01419587What this trial is testingKetogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)Who this might be right forCarcinoma, Non-Small-Cell Lung University of Iowa 11
Testing effectiveness (Phase 2)Study completedNCT03267121What this trial is testingApatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Squamous Cell Carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 38
Early research (Phase 1)Study completedNCT01839604What this trial is testingA Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular CarcinomaWho this might be right forAdvanced Adult Hepatocellular CarcinomaHepatocellular Carcinoma Metastatic AstraZeneca 58
Not applicableLooking for participantsNCT06098547What this trial is testingLIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)Who this might be right forIntrahepatic Cholangiocarcinoma Azienda Sanitaria Ospedaliera 10
Testing effectiveness (Phase 2)Study completedNCT00914355What this trial is testingStereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)Who this might be right forHepatocellular Carcinoma University Health Network, Toronto 92
Not applicableLooking for participantsNCT00488878What this trial is testingData Collection for Patients With Low Grade Ovarian or Peritoneal TumorsWho this might be right forLow Grade Ovarian Serous AdenocarcinomaMalignant Ovarian NeoplasmOvarian Carcinoma+3 more M.D. Anderson Cancer Center 2,000
Not applicableNot Yet RecruitingNCT06393543What this trial is testingInternational Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal CarcinomatosisWho this might be right forBRCA MutationSerous Tubal Intraepithelial CarcinomaOvarian Carcinoma+1 more Radboud University Medical Center 600
Testing effectiveness (Phase 2)UnknownNCT04553887What this trial is testingAlmonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II TrialWho this might be right forNon Small Cell Lung Cancer Tianjin Medical University Cancer Institute and Hospital 53
Testing effectiveness (Phase 2)Looking for participantsNCT06567314What this trial is testingPhase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell CarcinomaWho this might be right forCutaneous Squamous Cell Carcinoma M.D. Anderson Cancer Center 24
Not applicableActive Not RecruitingNCT06796816What this trial is testingBioimpedance Analysis in Perioperative Assessment in Thoracic SurgeryWho this might be right forLung ResectionAdenocarcinoma of Lung Azienda USL Reggio Emilia - IRCCS 1,000
Not applicableStudy completedNCT02635347What this trial is testingRemote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety StudyWho this might be right forLiver FailureCarcinoma, Hepatocellular Rutgers, The State University of New Jersey 31
Testing effectiveness (Phase 2)Study completedNCT00578149What this trial is testingBevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Dana-Farber Cancer Institute 45
Not applicableStudy completedNCT00042926What this trial is testingDiagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth CancerWho this might be right forHead and Neck Cancer Alliance for Clinical Trials in Oncology 161
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07169617What this trial is testingTesting the SurVaxM Vaccine for Lung Cancer PreventionWho this might be right forLung Carcinoma National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT01519414What this trial is testingTivantinib in Treating Patients With Metastatic Prostate CancerWho this might be right forHormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more National Cancer Institute (NCI) 78
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106What this trial is testingBCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC ParticipantsWho this might be right forNon-Muscle- Invasive Bladder Cancer AstraZeneca 100
Very early researchActive Not RecruitingNCT04219904What this trial is testingPET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical CancerWho this might be right forStage IA Cervical CancerStage IA1 Cervical CancerStage IA2 Cervical Cancer+4 more M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00425204What this trial is testingStudy for Patients Who Have Benefited and Tolerated Prior Panitumumab TreatmentWho this might be right forColorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more Amgen 31
Large-scale testing (Phase 3)Study completedNCT00917384What this trial is testingStudy of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and AdenocarcinomaWho this might be right forGastric CancerAdenocarcinoma Eli Lilly and Company 355